SavedAdd your journal

Journals / Türk Oftalmoloji Dergisi / 2014 / Cilt: 44 - Sayı: 3

Intravitreal bevacizumab ınjection therapy in a case with choroidal neovascular membrane secondary to toxoplasmosis retinochoroiditis

Toksoplazma koryoretinitine ikincil koroidal neovasküler membran olgusunda intravitreal bevacizumab enjeksiyon tedavisi

Evin ŞİNGAR
Sirel GÜNGÖR GÜR
Gürsel YILMAZ
İmren AKKOYUN
Pages
237–239
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intravitreal bevacizumab injection appears to be effective in the treatment of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis. (Turk J Ophthalmol 2014; 44: 237-9)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 57-year-old male patient presenting with visual loss in the left eye was diagnosed as choroidal neovascular membrane secondary to inactive toxoplasmosis retinochoroiditis scar.
📊
Key Findings & Data:The choroidal neovascular membrane regressed partially and the initial visual acuity improved from 1/10 to 3/10.
💡
Conclusion & Impact:Intravitreal bevacizumab injection appears to be effective in the treatment of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis. (Turk J Ophthalmol 2014; 44: 237-9)
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

A 57-year-old male patient presenting with visual loss in the left eye was diagnosed as choroidal neovascular membrane secondary to inactive toxoplasmosis retinochoroiditis scar. He underwent intravitreal bevacizumab injection as primary therapy. The choroidal neovascular membrane regressed partially and the initial visual acuity improved from 1/10 to 3/10. Intravitreal bevacizumab injection appears to be effective in the treatment of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis. (Turk J Ophthalmol 2014; 44: 237-9)

Özet

Elli yedi yaşında erkek hasta sol gözde görme kaybı ile başvurdu ve inaktif toksoplazma koryoretinit skarına ikincil koroidal neovasküler membran tanısı konuldu. Hastaya intravitreal bevacizumab enjeksiyonu uygulandı. Koroidal neovasküler membran kısmi olarak geriledi ve görme keskinliği 1/10dan 3/10a yükseldi. İntravitreal bevacizumab, toksoplazma koryoretinitlerine ikincil koroidal neovasküler membranların tedavisinde etkin görünmektedir. (Turk J Ophthalmol 2014; 44: 237-9)

🔖

Cite This Article

ŞİNGAR, E., GÜR, S. G., YILMAZ, G., AKKOYUN, İ. (2022). Intravitreal bevacizumab ınjection therapy in a case with choroidal neovascular membrane secondary to toxoplasmosis retinochoroiditis. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 3, 237–239. https://ajindex.com/articles/638117

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Fine SL, Owens SL, Haller JA, Knox DL, Patz A. Choroidal neovascularization as a late complicationof oculartoxoplasmosis. AmJOphthalmol. 1981;91:318- 22. Sivaprasad S, Moore AT. Choroidal neovascularisation in children. Br J Ophthalmol. 2008;92:451-4.
  2. Nessi F, Guex-Crosier Y, Ambresin A, Zografos L. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to toxoplasmic chorioretinal scar. Klin Monbl Augenheilkd. 2004;221:371-3.
  3. Oliveira LB, Reis PA. Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis. Graefes Arch Clin Exp Ophthalmol. 2004;242:1028-30.
  4. Ben Yahia S, Herbort CP, Jenzeri S, et al. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis. Int Ophthalmol. 2008;28:311-6.
  5. Rishi P, Venkataraman A, Rishi E. Combination photodynamic therapybevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J Ophthalmol. 2011;59:62-4.
  6. Rouvas A, Petrou P, Douvali M, et al. Intravitreal ranibizumab fortreatment of inflammatory choroidal neovascularization. Retina. 2011;31:871- 9. Shah NJ, Shah UN. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to oculartoxoplasmosis. Indian J Ophthalmol. 2011;59:318-9.
  7. Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol. 2004;48:386-91.
  8. Rouvas A, Liarakos VS, Theodossiadis P, et al. The effect of intravitreal ranibizumab on the fellow untreated eye with subfoveal scarring dueexudative age-related macular degeneration. Ophthalmologica. 2009;223:383-